|
Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see FDA Online Label Repository or DailyMed for these Medication Guides). More
| Drug Name |
Active Ingredient |
Form;Route |
Appl. No. |
Company |
Date |
| Avtozma |
Tocilizumab-Anoh |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS |
761420 |
CELLTRION |
10/06/2026 |
| Yusimry |
Adalimumab-Aqvh |
INJECTABLE;INJECTION |
761216 |
COHERUS BIOSCIENCES INC |
10/06/2026 |
| Riabni |
Rituximab-Arrx |
INJECTABLE;INJECTION |
761140 |
AMGEN INC |
10/06/2026 |
| Ruxience |
Rituximab-Pvvr |
INJECTABLE;INJECTION |
761103 |
PFIZER INC |
10/06/2026 |
| Zilurgisertib |
Zilurgisertib |
TABLET |
221198 |
INCYTE CORPORATION |
10/06/2026 |
| Sertraline |
Sertraline Hydrochloride |
CAPSULE;ORAL |
215133 |
ALMATICA PHARMA |
10/06/2026 |
| Zepzelca |
Lurbinectedin |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
213702 |
JAZZ PHARMACEUTICALS IRELAND LIMITED |
10/06/2026 |
| Olumiant |
Baricitinib |
TABLET;ORAL |
207924 |
ELI LILLY AND CO |
09/29/2026 |
|
This email was sent to Esdek@podam.pl using Granicus Communications Cloud on behalf of: U.S. Food and Drug Administration ·
10903 New Hampshire Ave · Silver Spring, MD · 20993-0002 · 1-888-INFO-FDA |
 |
|
|
